Schering-Plough and Orchid settle Clarinex patent litigation
This article was originally published in Scrip
Executive Summary
Schering-Plough and Orchid Chemicals and Pharmaceuticals have settled their patent litigation concerning desloratadine tablets 5mg and desloratadine 2.5mg and 5mg orally disintegrating tablets (ODT), generic versions of Schering-Plough's antihistamine products Clarinex and Clarinex RediTabs.